SUN PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 29.8%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 29.8%
Fri, 7 Feb

SUN PHARMA has announced its results for the quarter ended December 2019. Here is a detailed performance review of the same:

SUN PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-18*
3
Sep-19*
3
Dec-19*
QoQ ChangeYoY Change
Net SalesRs m77,40281,23481,5490.4%5.4%
Other incomeRs m1,9312,0091,199-40.3%-37.9%
TurnoverRs m79,33383,24282,747-0.6%4.3%
ExpensesRs m55,87363,33663,135-0.3%13.0%
Gross profitRs m21,52917,89718,4142.9%-14.5%
DepreciationRs m4,7114,7335,47015.6%16.1%
InterestRs m1,448839630-25.0%-56.5%
Profit before taxRs m17,30114,33413,513-5.7%-21.9%
TaxRs m2,7092,6603,27623.2%20.9%
Profit after taxRs m14,59211,67410,237-12.3%-29.8%
Gross profit margin%27.822.022.6
Effective tax rate%15.718.624.2
Net profit margin%18.414.012.4
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 5.4% on a year-on-year (YoY) basis. The expenses were up by 13.0% YoY during the same period.
  • The company's operating profit declined by 14.5% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 22.6% in 3QFY20 as against 27.8% in 3QFY19.
  • Depreciation charges increased by 16.1% and finance costs declined by 56.5% YoY, respectively.
  • Other income declined by 37.9% YoY during the quarter.
  • Net profit for the quarter declined by 29.8% YoY. Net profit margins during the quarter declined from 18.4% in 3QFY19 to 12.4% in 3QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 0.4% on a quarter-on-quarter (QoQ) basis. The expenses were down by 0.3% QoQ during the same period.
  • The company's operating profit increased by 2.9% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 22.6% in 3QFY20 as against 22.0% in 2QFY19.
  • Net profit for the quarter declined by 12.3% QoQ, while net profit margins declined from 14.0% in 2QFY19 to 12.4% in 3QFY20.

To see how SUN PHARMA has performed over the last eight quarters,please visit here.

Revealed: Top 3 Stocks for 2020 and Beyond

SUN PHARMA Share Price Performance

Over the last one year,SUN PHARMA share price has moved up from Rs 434.0 to Rs 434.5, registering a Gain of Rs 0.5 or around 0.1%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,191.1 (up 1.0%). Over the last one year it has moved up from 14,067.5 to 14,191.1, a gain of 124 points (up 0.9%).

Overall, the S&P BSE SENSEX is up 11.4% over the year.

Current Valuations

At the current price of Rs 434.5, the price to earnings (P/E) ratio of SUN PHARMA stands at 23.7 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 2.5 times.

Equitymaster requests your view! Post a comment on "SUN PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 29.8%". Click here!

  

Related Views on News

SUN PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 31.6% (Quarterly Result Update)

May 28, 2020 | Updated on May 28, 2020

For the quarter ended March 2020, SUN PHARMA has posted a net profit of Rs 5 bn (down 31.6% YoY). Sales on the other hand came in at Rs 82 bn (up 14.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 35.3% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, SUN PHARMA has posted a net profit of Rs 15 bn (up 35.3% YoY). Sales on the other hand came in at Rs 84 bn (up 15.9% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

Before You Buy Your First Electric Vehicle Consider Buying this Stock(Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Large Opportunities Are Coming Our Way

Aug 5, 2020

Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.

Is It Time to Book Profits in Gold and Silver?(Fast Profits Daily)

Aug 10, 2020

Gold and silver have delivered phenomenal returns this year. Is it time to take some money of the table?

Forget the Nifty and Sensex for the Next 1 or 2 Years and Focus on These Stocks(Profit Hunter)

Aug 6, 2020

Stocks from the essential small cap space are likely to be outperformers over the next 1 or 2 years.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Aug 11, 2020 03:37 PM

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA - ADCOCK INGRAM COMPARISON

COMPARE SUN PHARMA WITH

MARKET STATS